Progeny 3’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Progeny 3's ASND Position: Q2 2026 in Review
Progeny 3 held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 5,230 shares worth $1.39M. The position accounts for 0.07% of the portfolio, ranked #29.
Progeny 3 first reported a position in ASND in Q4 2025 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Progeny 3 held 5,230 shares of Ascendis Pharma A/S worth $1.39M as of Q2 2026.
- Progeny 3 left its Ascendis Pharma A/S share count unchanged in Q2 2026.
- Ascendis Pharma A/S made up 0.07% of Progeny 3's portfolio in Q2 2026, its #29 holding.
- Progeny 3 first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 3 quarters since.
- 315 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Progeny 3's 13F filing for Q2 2026, filed 14 Aug 2026.